Searched for
DRUG DISCOVERY INNOVATION
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- Mark Zuckerberg's philanthropic venture unveils AI world model for drug discoveryBiohub, a venture by Mark Zuckerberg and Priscilla Chan, has launched a protein biology world model. This advanced AI tool aims to speed up...
- Global firms rethink GCC hiring in India as AI shifts skill demandGlobal firms in India are hiring cautiously. Artificial intelligence is changing job roles, making it harder to find talent with advanced t...
- An SNL 'All Drug Olympics?' Not quite. But these Enhanced Games are no jokeThe "Enhanced Games" in Las Vegas allows athletes to use performance enhancers, aiming to challenge mainstream sports' anti-doping efforts ...
- Amaravati still under construction, but Quantum Valley project already luring deep tech startups, scientistsAmaravati, a new city in Andhra Pradesh, is becoming a hub for quantum computing. A technology park called Quantum Valley is attracting sci...
- Fractal bets big on enterprise AI despite TMT weakness dragging revenue growthAnalytics firm Fractal sees robust enterprise AI growth, with banking and life sciences booming at 40% and 80% respectively. Despite a dip ...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- J&J sees AI halving the time to generate drug development leadsJohnson & Johnson is leveraging artificial intelligence to significantly speed up drug development. The company has halved the time needed ...
- ET Most Innovative AI Product Awards 2026: Honouring the innovations powering India's next economyThe ET Most Innovative AI Product Awards 2026 brings together 11 distinct categories that reflect where artificial intelligence is deliveri...
- India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
- Large AI firms hoovering maximum funding, not enough for smaller startups: Y Combinator’s Ankit GuptaAnkit Gupta spoke to ET ahead of the accelerator’s Startup School event in Bengaluru on April 18 — the first in India. In order to tap aspi...
- Deloitte launches quantum tech facility at IIT BombayDeloitte India has launched a new quantum technology facility at IIT Bombay. This center, named QCoDE, aims to boost quantum adoption for I...
- HRD, S&T ministries launch 'Drug Discovery Hackathon' to develop anti-COVID drugThe initiative is being jointly carried out by the 'MHRD's Innovation Cell (MIC)', All India Council for Technical Education (AICTE) and th...
- Investment in drug development firm to fetch Jubilant Life upto $22.6 millionJubilant Life Sciences today said its US arm stands to receive up to USD 22.6 million following the acquisition of a drug development firm.
- Novartis patent verdict not a problem, other issues pose risks to Indian pharma innovationThe recent Supreme Court judgement against Novartis has reopened old debates on drug patents, affordable healthcare and India as a destinat...
- India more mature for drug discovery than China: ReportRising research and development initiatives in the pharma sector has made India a more mature place for drug discovery activities than Chin...
Load More
